G.K. Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 12-12-2024
- Paid Up Capital ₹ 1.27 M
as on 12-12-2024
- Company Age 32 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.70 Cr
as on 12-12-2024
- Satisfied Charges ₹ 3.25 Cr
as on 12-12-2024
- Revenue -2.46%
(FY 2021)
- Profit 48.53%
(FY 2021)
- Ebitda -101.80%
(FY 2021)
- Net Worth 2.15%
(FY 2021)
- Total Assets 5.13%
(FY 2021)
About G.K. Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.27 M.
The company currently has active open charges totaling ₹2.70 Cr. The company has closed loans amounting to ₹3.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kalpana Ray and Debashree Sharma serve as directors at the Company.
- CIN/LLPIN
U33111WB1992PTC056989
- Company No.
056989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Bardhaman, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at G.K. Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpana Ray  | Director | 01-Mar-1993 | Current |
| Debashree Sharma | Director | 26-Aug-2024 | Current |
Financial Performance of G.K. Diagnostics.
G.K. Diagnostics Pvt. Ltd., for the financial year ended 2021, experienced Minor drop in revenue, with a 2.46% decrease. The company also saw a substantial improvement in profitability, with a 48.53% increase in profit. The company's net worth moved up by a moderate rise of 2.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G.K. Diagnostics?
In 2021, G.K. Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Assure Wellness Clinic & Diagnostic Cent Re LlpActive 3 years 10 months
Debashree Sharma is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Jan 2018 | ₹2.70 Cr | Open |
Axis Bank Limited Creation Date: 29 Feb 2016 | ₹3.00 Cr | Satisfied |
Axis Bank Limited Creation Date: 03 Sep 2010 | ₹1.65 M | Satisfied |
How Many Employees Work at G.K. Diagnostics?
Unlock and access historical data on people associated with G.K. Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G.K. Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G.K. Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
